For Biogen, dapirolizumab pegol is part of a push ... "Our hypothesis is that impacting the CD40L pathway, a central mechanism in immune response, would translate to significant impact on SLE ...
The promise of CD40L blockers is to modulate the immune system rather than suppress it. Traditional immunosuppression drugs ...